O‐GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer
Z Yu, H He, B Jiang, J Hu - Molecular Biotechnology, 2024
Colorectal cancer (CRC) metastasis is challenging for improved clinical outcomes.
The casein kinase 2 alpha 1 (CSNK2A1) is an oncogene involved in several
cancers. This study aimed to investigate the influence of CSNK2A1 on CRC
progression and the related molecular mechanism. The CSNK2A1 levels were
predicted using bioinformatic analysis and were measured using quantitative real-
time polymerase chain reaction (qRT-PCR). Cell phenotypes were analyzed using …
The casein kinase 2 alpha 1 (CSNK2A1) is an oncogene involved in several
cancers. This study aimed to investigate the influence of CSNK2A1 on CRC
progression and the related molecular mechanism. The CSNK2A1 levels were
predicted using bioinformatic analysis and were measured using quantitative real-
time polymerase chain reaction (qRT-PCR). Cell phenotypes were analyzed using …
| • | 引用: Current Targeted Therapy for Metastatic Colorectal Cancer  |
 |
 |
 |
 |
[PDF] Deciphering glycoprotein VI signalling in platelet activation: integration of functional and computational modelling data
YFH Cheung - 2023
This research in this thesis was supported by a joint PhD scholarship of the
European Union's Horizon 2020 research and innovation program under the Marie
Sklodowska-Curie grant agreement TAPAS No. 766118. This thesis is submitted as a
result of the joint doctorate programme of Yam Fung Hilaire Cheung at Maastricht
University and the University of Birmingham, for obtaining a double PhD degree.
Admission to the joint doctorate programme has been confirmed in the Individual …
European Union's Horizon 2020 research and innovation program under the Marie
Sklodowska-Curie grant agreement TAPAS No. 766118. This thesis is submitted as a
result of the joint doctorate programme of Yam Fung Hilaire Cheung at Maastricht
University and the University of Birmingham, for obtaining a double PhD degree.
Admission to the joint doctorate programme has been confirmed in the Individual …
| • | 引用: Involvement of the snake toxin receptor CLEC-2, in podoplanin … |
|
|
|
|
[PDF] Traitements du cancer du sein: thérapie personnalisée et thérapie généralisée
A Burguin - 2023
Résumé Le cancer du sein est le cancer le plus fréquent au niveau mondial chez la
femme, représentant 12% des nouveaux cas de cancers en 2020. C'est une maladie
complexe et hétérogène classée en fonction de l'expression de trois marqueurs
moléculaires: le récepteur aux estrogènes (ER), le récepteur à la progestérone (PR)
et le récepteur épidermique humain 2 (HER2) qui donnent lieu à quatre sous-types
moléculaires qui sont les sous-types luminal A (ER+ et/ou PR+, HER2-), luminal B …
femme, représentant 12% des nouveaux cas de cancers en 2020. C'est une maladie
complexe et hétérogène classée en fonction de l'expression de trois marqueurs
moléculaires: le récepteur aux estrogènes (ER), le récepteur à la progestérone (PR)
et le récepteur épidermique humain 2 (HER2) qui donnent lieu à quatre sous-types
moléculaires qui sont les sous-types luminal A (ER+ et/ou PR+, HER2-), luminal B …
| • | 引用: The role of MMP-1 in breast cancer growth and metastasis to the … |